A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery

NCT04025047 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4147

Last updated 2019-07-23

No results posted yet for this study

Summary

This is a multi-center, prospective, observational, hospital-based registry of pelvic organ prolapse(POP) patients who having trans-vaginal mesh implantation with 12 month and 36 month follow-up.To investigate the incidence of postoperative complications according to the International Urogynecological Association/International Continence Society (IUGA/ICS) complication classification system(the Category- Time-Site(CTS) coding).

Conditions

  • Pelvic Organ Prolapse

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Fuzhou General Hospital

    collaborator OTHER
  • Obstetrics & Gynecology Hospital of Fudan University

    collaborator OTHER
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    collaborator OTHER
  • Affiliated Wuhu Clinical College of Nantong University

    collaborator UNKNOWN
  • The Second Hospital of Anhui Medical University

    collaborator OTHER
  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • Changsha Hospital for Maternal and Child Health Care

    collaborator OTHER
  • The Third Xiangya Hospital of Central South University

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Shenzhen People's Hospital

    collaborator OTHER
  • Fourth Medical Center of PLA General Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Second Hospital of Jilin University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Yantai Yuhuangding Hospital

    collaborator OTHER
  • Shanxi Coal Center Hospital

    collaborator UNKNOWN
  • Mianyang Central Hospital

    collaborator OTHER
  • West China Second University Hospital

    collaborator OTHER
  • Chongqing Medical Center for Women and Children

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • Shaanxi Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • People's Hospital of Xinjiang Uygur Autonomous Region

    collaborator OTHER
  • Dalian Maternity and Child Care Hospital

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Shanghai 10th People's Hospital

    collaborator OTHER
  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER
  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER
  • Affiliated Renhe Hospital of China Three Gorges University, China

    collaborator UNKNOWN
  • Guizhou Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of the Medical College, Shihezi University,China

    collaborator UNKNOWN
  • Yangpu District Central Hospital Affiliated to Tongji University

    collaborator OTHER
  • Wuhan Central Hospital

    collaborator OTHER
  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Lan Zhu, MD · Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-10
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04025047 on ClinicalTrials.gov